Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy | |
Gu, Junlian; Cheng, Yanli; Wu, Hao; Kong, Lili; Wang, Shudong; Xu, Zheng; Zhang, Zhiguo; Tan, Yi; Keller, Bradley B.; Zhou, Honglan | |
刊名 | DIABETES |
2017 | |
卷号 | 66期号:2 |
ISSN号 | 0012-1797 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3540134 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Gu, Junlian,Cheng, Yanli,Wu, Hao,et al. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy[J]. DIABETES,2017,66(2). |
APA | Gu, Junlian.,Cheng, Yanli.,Wu, Hao.,Kong, Lili.,Wang, Shudong.,...&Cai, Lu.(2017).Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.DIABETES,66(2). |
MLA | Gu, Junlian,et al."Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy".DIABETES 66.2(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论